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The Receptor for Advanced Glycation End Products
Is Highly Expressed in the Skin and Upregulated
by Advanced Glycation End Products and Tumor
Necrosis Factor-Alpha
Christina Lohwasser1,6, Daniel Neureiter2,3,6, Bernd Weigle4, Thomas Kirchner2 and Detlef Schuppan1,5
Advanced glycation end products (AGEs) form non-enzymatically from reactions of proteins with reducing
sugars. In the skin, AGEs were reported to accumulate in dermal elastin and collagens and to interact
nonspecifically with the cell membrane of dermal fibroblasts. Therefore, AGEs may influence the process of skin
aging. We investigated the presence of the AGE receptor RAGE in skin and the influence of AGEs on receptor
expression and the formation of extracellular matrix (ECM). Sections of sun-protected and sun-exposed skin
were analyzed with monoclonal antibodies against (RAGE), heat-shock protein 47, factor XIIIa, CD31, and CD45.
RAGE was mainly expressed in fibroblasts, dendrocytes, and keratinocytes and to a minor extent in endothelial
and mononuclear cells. Human foreskin fibroblasts (HFFs) highly expressed RAGE on the protein and mRNA
level when analyzed by quantitative Western blotting and real-time PCR. Incubation of HFFs with the specific
RAGE ligand Ne-(carboxymethyl)lysine-modified BSA (CML-BSA) and tumor necrosis factor-alpha resulted in
significant upregulation of RAGE expression. CML-BSA induced a mildly profibrogenic pattern, increasing
connective tissue growth factor, transforming growth factor-beta (TGF-b) 1, and procollagen-a1(I) mRNA,
whereas expression of matrix metalloproteinase (MMP)-1, -2, -3, and -12 was unaffected. We conclude that in
HFFs, AGE–RAGE interactions may influence the process of skin aging through mild stimulation of ECM gene
expression.
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INTRODUCTION
Advanced glycation end products (AGEs) result from non-
enzymatic glycation of the amino groups of proteins with
reducing sugars such as glucose. The specific AGE
Ne-(carboxymethyl)lysine (CML) modifies skin elastin, espe-
cially during UV-induced photoaging (Mizutari et al., 1997),
and AGEs accumulate on skin elastin and collagen, interfer-
ing with normal skin function (Wondrak et al., 2002).
Increased AGE levels in skin collagen are found during the
normal process of aging, in diabetes or chronic renal failure
(Schnider and Kohn, 1980, 1981; Monnier et al., 1984, 1999;
Dyer et al., 1993; Jeanmaire et al., 2001; Meng et al., 2001).
The formation of AGEs on skin collagen favors collagen
crosslinking, resulting in decreased degradability by, for
example, matrix metalloproteinases (MMPs) and impaired
dermal regeneration. Okano et al. (2002) postulated that
AGEs bind to fibroblast cell membranes, contributing to the
progression of skin aging.
Receptor for AGE (RAGE), a member of the immunoglo-
bulin superfamily of cell surface receptors, interacts with
several ligands, especially with CML (Kislinger et al., 1999).
RAGE is expressed in a variety of tissues and cells, including
cells of the vessel walls, neural tissues, cardiac myocytes,
monocytes and macrophages, T-lymphocytes, and mesangial
cells (Brett et al., 1993; Wautier and Guillausseau, 2001). The
role of RAGE in interactions of AGEs with dermal fibroblasts,
especially in the context of skin aging, remains largely unclear.
During skin aging and in sun-exposed skin, the normal
fibrillary pattern of dermal extracellular matrix (ECM) is
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replaced by non-functional ECM, in which the normally
divalent collagen crosslinks have been replaced by trivalent
crosslinks, causing thickening and tangling of collagen fibrils
(Kligman and Kligman, 1986; Wulf et al., 2004).
The major structural components of the dermal ECM are
collagen I and III, accounting for over 70 and 15%,
respectively, of skin dry weight and providing the dermis
with tensile strength and stability. Other structurally impor-
tant skin collagens are types IV, V, VI, and XIV. Collagen
metabolism is a complex process requiring balanced synth-
esis and degradation by, for example, MMPs, and the action
of cytokines. Thus, MMP production is stimulated through
tumor necrosis factor-alpha (TNF-a) released after UV
exposure, leading to degradation of collagen and elastin
and, hence, dermal photoaging (Lovell et al., 1987;
Koivukangas et al., 1994; Brenneisen et al., 1996). The
interstitial collagenases MMP-1 and -13 preferentially
degrade collagens I and III, whereas the gelatinases MMP-2
and -9 are responsible for the breakdown of collagen IV, the
major basement membrane protein, and also of collagen I
when complexed with tissue inhibitor of MMP (TIMP-2) and
MMP-14. MMP-3 cleaves various ECM substrates including
collagen IV, proteoglycans, fibronectin, and laminin and
activates other pro-MMPs (Burgeson, 1982; Brenneisen et al.,
2002). The macrophage metalloelastase MMP-12 is respon-
sible for the degradation of elastin and a broad range of
matrix and non-matrix substrates (Chandler et al., 1996;
Shipley et al., 1996; Gronski et al., 1997). Central profibro-
genic cytokines are transforming growth factor-beta 1 (TGF-b1)
and connective tissue growth factor (CTGF), a downstream
mediator of TGF-b1 action.
In the present study, we investigated the influence of
glycated proteins (AGEs) on skin aging by studying their
influence on ECM-related gene expression in skin fibroblasts.
This was correlated to expression of RAGE in vitro and in vivo
and to the induction of RAGE by the proinflammatory
cytokine TNF-a.
RESULTS
RAGE expressed in different human skin tissues
Comparison of sun-protected skin from younger and older
patients in the same anatomical region (breast). Sun-
protected skin of younger patients showed a normal
morphological architecture of the cutis without the typical
signs of chronological aging or photoaging (Figure 1a). Sun-
protected skin from older patients displayed signs of
chronological aging (Figure 1i): (1) atrophy of the epidermis
and (2) hypocellularity in the papillary layer of the dermis as
shown by the reduced amount of factor XIIIa-positive
dendrocytes (Figure 1j), CD31-positive endothelial cells
(Figure 1k), and heat-shock protein (HSP)47-positive skin
fibroblasts (Figure 1m and n). The number of CD45-positive
lymphocytes was increased (Figure 1l). In the skin of young
donors, RAGE could be localized mainly in the superficial
and middle zone of the epidermis (Figure 1g and h), whereas
in the skin of older patients, RAGE was located in the middle
and basal zone of the epidermis (Figure 1o). In fetal skin,
RAGE was predominantly found in the upper zone of the
epidermis (data not shown). In the dermis, RAGE-positive
cells were mainly detected in the papillary layer of younger
donors (Figure 1g and h), compared to the reticular layer in
older donors (Figure 1o and p). In fetal dermis, only few cells,
mainly endothelial cells, were RAGE positive (data not
shown).
Comparison of sun-protected versus sun-exposed skin from
older patients in different anatomical regions (knee vs face).
Sun-protected skin from older patients showed atrophy of the
epidermis (Figure 1q) and hypocellularity, mainly in the
upper dermis, of dendrocytes (Figure 1r), vascular cells
(Figure 1s), lymphocytes (Figure 1t), and skin fibroblasts
(Figure 1u and v). In sun-exposed skin from older patients,
typical signs of photosensitivity were observed such as deep
solar elastosis (Figure 1y), scattered dendrocytes and stellate
fibroblasts (Figure 1z and cc), dilation of vessels (Figure 1aa),
and small aggregates of lymphoid cells (Figure 1bb). In sun-
protected and sun-exposed skin, RAGE was predominantly
found in the basal layer and the adjacent middle zone of the
epidermis (Figure 1w, ee, and ff). Additionally, in the
epidermis of sun-exposed tissues, an inhomogeneous and
patchy RAGE positivity of keratinocytes was observed (Figure
1ff). In the dermis, mainly in the papillary layer, of sun-
exposed skin (Figure 1ee and ff), the number of RAGE-
positive cells was increased compared to sun-protected skin
(Figure 1w and x). RAGE-positive cells were localized around
areas of solar elastosis, but RAGE was not detectable in areas
with intact extracellular matrix (Figure 1ff).
The distribution patterns of RAGE-expressing cells were
semiquantified as summarized in Table 1.
Cellular expression patterns of RAGE in skin. In order to
characterize RAGE-expressing cells (Figure 1g, h, o, p, w, x,
ee, and ff), colocalization studies were performed by using
consecutive sections counterstained for HSP47 (Figure 1e, f,
m, n, u, v, cc, and dd, higher magnification), factor XIIIa (Figure
1b, j, r, and z), CD31 (Figure 1c, k, s, and aa), and CD45 (Figure
1d, l, t, and bb). In all instances (normal, aged, and sun-exposed
skin), the majority of RAGE-positive cells were identified as skin
fibroblasts, dendrocytes, and endothelial cells, whereas only
few CD45-positive lymphocytes expressed RAGE.
Human foreskin fibroblasts express RAGE
High-level expression of RAGE by untreated human foreskin
fibroblasts (HFFs) was confirmed by semiquantitative Western
blotting using a monoclonal anti-RAGE antibody (Figure 2).
CML-BSA and TNF-a upregulate RAGE protein and mRNA
expression
HFF were exposed to increasing concentrations of CML-BSA,
lysed, and subjected to Western blotting for RAGE and
b-actin. CML-BSA at 10 and 50mg/ml upregulated RAGE
protein expression more than three-fold (Po0.05), whereas no
upregulation was found at 100mg/ml (Figure 3a). In addition,
RAGE transcript levels were investigated by real-time PCR
(Figure 3b), revealing a 1.5-fold upregulation after addition of
50mg/ml CML-BSA compared to BSA (P¼ 0.057).
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Figure 1. Expression of RAGE, HSP47, factor XIIIa, CD31, and CD45 in human skin. Hematoxylin–eosin stainings (a) showed basic morphological changes of
the specimen due to aging and/or sun-aging. Factor (b) XIIIa, (c) CD31, (d) CD45, (e/f) HSP47, and (g/h) RAGE protein expression was investigated on
consecutive sections of younger sun-protected (a–h, breast), older sun-protected (i–p, breast), older sun-protected (q–x, popliteal fossa), and older sun-exposed
(y–ff, face) skin. Expression of RAGE was found mainly in the basal zone of the epidermis. RAGE was overexpressed in fibroblasts and dendrocytes close to areas
of older skin damaged by sun exposure. Bar=200 mm.
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When HFFs were exposed to increasing concentrations of
TNF-a under serum-free conditions for 24 hours, RAGE
protein expression was upregulated dose-dependently up to
two-fold (Figure 4).
CML-BSA induces ECM-related gene expression
HFFs were incubated with CML-BSA or BSA as control,
and mRNA expression was determined by real-time PCR
(Figure 5). CML-BSA significantly upregulated CTGF, TGF-b1,
and procollagen-a1(I) (PC-a1(I)) mRNA expression, whereas
there was a trend for downregulation of MMP-3 mRNA and
for upregulation of MMP-2 mRNA. Expression of MMP-1 and
MMP-12 mRNA remained unchanged.
DISCUSSION
Fibroblasts play a central role in the turnover of the dermal
extracellular matrix and are therefore involved in skin aging.
AGEs were shown to accumulate on elastin and collagens
and to bind to fibroblast membranes at concentrations of
2.5–40 mg/ml (Okano et al., 2002). AGEs bind to several
cellular receptors, including scavenger receptor class A and
B, 80K-H phosphoprotein, galectin-3, lactoferrin, and speci-
fically to RAGE. RAGE is expressed on several cells, and
prominently on human microvascular endothelial cells
Table 1. Semiquantification of immunohistochemical
RAGE staining indicating the distribution pattern of
RAGE
Sun-
protected
breast
(young)
Sun-
protected
breast (old)
Sun-
protected
knee (old)
Sun-
exposed face
(old)
Upper
epidermis
+++ +/++ +/(++) +/(++)
Lower
epidermis
+/++ +++ +++ +++
Upper dermis ++ + + ++/(+++)
Lower dermis + ++ ++ ++
+ weak, ++ moderate, +++ strong intensity of RAGE; ( ) indicates that this
intensity level was only focally detected.
55 kDa
42 kDa
RAGE
-Actin
Figure 2. RAGE is expressed in HFFs. HFF were extracted, separated with
12% SDS-PAGE, and blotted using the monoclonal anti-RAGE antibody
(1:100 dilution). Binding was visualized with a horseradish peroxidase-
labeled secondary antibody. The lower band represents b-actin (monoclonal
antibody, 1:5,000 dilution), which was used to control for protein loading.
This is a representative blot from at least three independent experiments
performed in duplicate.
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Figure 3. CML-BSA upregulates RAGE protein and mRNA expression in
HFFs. (a) HFFs were treated with 50 mg/ml BSA as control and 10–100 mg/ml
CML-BSA for 24 hours in starvation medium before extraction, separation,
and blotting with the anti-RAGE antibody. Bars represent mean RAGE protein
expression relative to b-actin (7SD) derived from three independent
experiments performed in duplicate. (b) HFFs were incubated with 50 mg/ml
BSA or CML-BSA for 24 hours in serum-free medium before RNA extraction
and determination of RAGE mRNA expression by real-time PCR. (c) Bars
represent mean RAGE mRNA expression relative to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA (7SD) from two independent
experiments performed in quadruplicate. *Po0.05 versus BSA.
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Figure 4. TNF-a upregulates RAGE protein and mRNA expression in HFFs.
(a) HFF were treated with 0–10 ng/ml TNF-a for 24 hours in starvation medium
before extraction, separation, and blotting with the anti-RAGE antibody. Bars
represent mean RAGE protein expression relative to b-actin (7SD) derived
from three independent experiments performed in duplicate. (b) HFFs were
incubated with 0 or 1 ng/ml TNF-a for 24 hours in starvation medium before
RNA extraction and determination of RAGE mRNA expression by real-time
PCR. (c) Bars represent mean RAGE mRNA expression relative to GAPDH
(7SD) from two independent experiments performed in quadruplicate.
**Po0.01 versus 0 ng/ml TNF-a.
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Figure 5. The specific RAGE ligand CML-BSA modulates ECM-related gene
expression in HFFs. HFFs were treated with 50 mg/ml BSA or CML-BSA for
24 hours in starvation medium, extracted, and expression of CTGF, TGF-b1,
PC-a1(I), MMP-1, MMP-2, MMP-3, and MMP-12 mRNAs was quantified by
real-time PCR relative to GAPDH mRNA. Bars represent means7SD derived
from two independent experiments performed in quadruplicate. *Po0.05
versus BSA.
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(Valencia et al., 2004). In these cells, CML-ovalbumin
stimulated NF-kB signaling mainly attributed to interactions
with RAGE (Kislinger et al., 1999). However, it is not known
if and how far AGEs and RAGE may be involved in skin aging
and ECM formation by dermal fibroblasts.
We could demonstrate for the first time that RAGE protein
is highly expressed in human skin as shown by immuno-
histological analysis of younger versus older, sun-exposed
versus sun-protected, and of fetal skin. In older patients
(independent of sun exposure), RAGE was predominantly
found in basal areas where skin regeneration occurs,
compared to epidermal expression of RAGE in fetal skin
and an intermediate expression pattern in older sun-protected
skin. RAGE expression was increased in sun-exposed skin.
We cannot exclude that anatomical differences between the
largely sun-protected popliteal fossa and sun-exposed face
may be partly responsible for the observed differences in
RAGE expression, but for ethical reasons sun-protected and
sun-exposed skin from the same location could not be
obtained. However, we found no major differences in RAGE
expression between sun-protected skin from older breast and
knee, indicating that our results represent changes related to
sun exposure and not local differences of expression. RAGE-
positive cells were mainly keratinocytes, skin fibroblasts,
dermal dendrocytes, and endothelial cells, but some expres-
sion was also observed in lymphocytes.
Keratinocytes, which represent 95% of epidermal cells,
are metabolically highly active and secrete growth factors
and cytokines, such as the proinflammatory cytokine TNF-a
and interleukin-1, -6, and -8. During skin aging, such as
through UV exposure, keratinocytes degenerate and release
vascular endothelial growth factor and basic fibroblast
growth factor, resulting in endothelial cell activation and
enhanced angiogenesis, favoring a wound-healing response
(Toyoda et al., 2001). Endothelial cells also express MMP-1,
-2, and -3, which degrade ECM components, and inter-
cellular adhesion molecule-1, thus recruiting circulating
macrophages and leukocytes, which secrete collagenases
and myeloperoxidases that can degrade the ECM (Giacomoni
and Rein, 2001).
As we found the highest RAGE expression in fibroblasts in
the (upper) dermis, we performed cell culture experiments to
show that HFFs express high levels of RAGE protein and
mRNA. Based on its amino-acid sequence, RAGE has a
molecular weight of approximately 42 kDa (Neeper et al.,
1992). The RAGE band in our studies migrated at about
57 kDa, similar to RAGE of hepatic stellate cells (Fehrenbach
et al., 2001; our own unpublished observation). Others
previously reported RAGE as two distinct proteins migrating
at around 30 and 50 kDa in the fibroblast cell line
GM05757A (Owen et al., 1998) or as a 50 kDa species in
RAGE-transfected 293 cells (Neeper et al., 1992). Further-
more, RAGE was detected in lung extracts at a size of 35 kDa
(Brett et al., 1993; Wautier et al., 1994). These size
differences are likely due to glycosylation of the extracellular
domain (Neeper et al., 1992) or to post-translational
processing and proteolytic cleavage (Brett et al., 1993; Yan
et al., 1994; Renard et al., 1999).
RAGE expression in skin fibroblasts was inducible by
CML-BSA, a specific RAGE ligand. AGEs accumulate on
collagen and elastin in the skin, especially during the process
of aging and after UV irradiation. In addition, we observed
that the proinflammatory cytokine TNF-a, which is released
after UV radiation to the skin and which is incriminated in
skin aging (Yarosh et al., 2000a, b), enhanced RAGE
expression in HFF. RAGE induction through AGE-BSA and
TNF-a was shown before in human umbilical vein endo-
thelial cells (Tanaka et al., 2000), and through AGE-BSA in
normal rat kidney fibroblasts (Huang et al., 2001).
Finally, we demonstrated that AGEs alter ECM-related
gene expression in HFFs, which likely leads to enhanced
turnover of the collagenous ECM in the skin. This addition of
CML-BSA to HFFs significantly upregulated expression of
CTGF, TGF-b1, and PC-a1(I), whereas MMP-2 expression
was nonsignificantly induced. Expression of MMP-1, -3, and
-12 remained largely unaffected by the addition of CML-BSA.
CTGF induces ECM formation in fibroblasts, in part by
mediating actions of the key profibrogenic cytokine TGF-b1
(Frazier et al., 1996; Grotendorst, 1997). Induction of CTGF
by 100mg/ml AGE-BSA but not the RAGE-specific ligand
CML-BSA in human dermal fibroblasts on a mRNA and
protein basis has been reported previously (Twigg et al.,
2001). In line with our data, Huang et al. (2001) described
that AGEs increased collagen production in normal rat
kidney fibroblasts, whereas others found a decrease in a
human fibroblasts cell line or no change in human skin
fibroblasts (Owen et al., 1998; Okano et al., 2002). As we
used the specific RAGE ligand CML-BSA, the divergent results
may be due to stimulation of other AGE receptors than
RAGE. Our overall findings show that in HFF, CML-BSA
mildly stimulates interstitial collagen production (procollagen
I, TGF-b1, CTGF), with a trend toward production of
proteases, such as MMP-2, that destroy basement mem-
branes. As UV radiation results in overall ECM degradation,
especially of elastin, dermal fibroblasts and endothelial cells
that were previously shown to release ECM proteolytic
activity (Giacomoni and Rein, 2001) appear to play opposing
roles with regard to skin aging and remodeling, with
endothelial cells likely driving the degenerative changes of
the dermis.
In conclusion, we could show that RAGE is highly
expressed in skin and upregulated in sun-exposed skin.
We could demonstrate that HFF highly express functional
RAGE, and that a specific RAGE ligand upregulates RAGE
expression and induces a mildly profibrogenic ECM remodel-
ing in HFF.
MATERIALS AND METHODS
Materials
Antibodies against CD31 and CD45, biotinylated rabbit anti-mouse
antibodies, non-immune mouse IgG1, streptavidin–biotin-com-
plexed alkaline phosphatase, target retrieval solution, pH 6.0, and
the catalyzed signal amplification system using biotinylated tyramids
were supplied by Dako (Glostrup, Denmark). The antibodies against
factor XIIIA (Ab-1) were from Lab Vision (Fremont, CA) and against
HSP47 from Stressgen (Victoria, Canada). Avidin and biotin were
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supplied by Vector Laboratories (Burlingame, CA). BSA, TNF-a,
monoclonal anti-b-actin clone AC-15, goat anti-mouse IgG-peroxi-
dase, and Fast Red were purchased from Sigma-Aldrich (Taufkirch-
en, Germany). DMEM was from Biochrom (Berlin, Germany). Fetal
calf serum was purchased from PAA Laboratories (Linz, Austria).
Monoclonal anti-RAGE antibody was produced as previously
described (Srikrishna et al., 2002). The Bradford protein assay was
from Bio-Rad Laboratories GmbH (Munich, Germany). Detoxi-GelTM
endotoxin-removing gel was from Pierce (Rockford, IL) and the
limulus amebocyte lysate endotoxin test kit from Bio-Whittaker
(Walkersville, MD). SuperScriptTM II RNase reverse transcriptase and
Novexs 12% tris-glycine precast gels without SDS were from
Invitrogen (Karlsruhe, Germany). PeqGOLD RNAPure, dTTP, dGTP,
dCTP, and dATP (100 mM each) were obtained from PeqLab
Biotechnologie GmbH (Erlangen, Germany) and Oligo(dT)15 primer,
random primers, and RNasins ribonuclease inhibitor from Promega
(Madison, WI). LightCycler fast start DNA master hybridization
probes, LightCycler capillaries, LightCycler instrument, and Com-
pleteTM proteinase inhibitor cocktail were from Roche Diagnostics
(Mannheim, Germany). The enhanced chemiluminescence Western
blotting detection reagents were from Amersham Pharmacia Biotech
(Freiburg, Germany) and nitrocellulose membranes from Schleicher
& Schuell GmbH (Dassel, Germany). The mycoplasma-test Venor
GeMs was purchased from Minerva Biolabs GmbH (Berlin,
Germany). Citric acid monohydrate was from Merck (Darmstadt,
Germany).
Skin samples and histological analysis
Informed written consent of patients was obtained before tissue
resection and the study was conducted according to the Declaration
of Helsinki Principles. All studies were approved by the ethical
committee of the University of Erlangen-Nuernberg. To evaluate age
dependency of RAGE expression, six skin samples from mammary
reductions of younger patients (average age 32.275.6 years) and
one sample from fetal skin (week 19 of gestation, from autopsy) were
compared to six skin samples from older, non-exposed mammary
tissue derived from breast ablation due to cancer (average age
73.677.3 years). To evaluate sun exposure-dependent RAGE
expression, six skin samples derived from non-exposed popliteal
fossa of above-knee amputations due to arterial occlusive disease
(average age 74.5711.6 years) were compared to 10 skin samples
derived from sun-exposed healthy resection margins of surgically
excised facial tumors (average age 67.0712.1 years) (Table 2).
Specimens were immediately fixed in 10% buffered formalin. After
embedding in paraffin, 5 mm sections were cut and stored at room
temperature. Routine hematoxylin–eosin staining was used to
evaluate basic histomorphology of the specimens.
For immunohistology, consecutive sections were deparaffinized
using graded alcohol. To prevent nonspecific binding of antibodies,
sections were blocked with avidin and biotin. Sections were
incubated overnight at room temperature using monoclonal
antibodies to RAGE (1:50), CD45 (1:50), and HSP47 (1:100) (all
pretreated with target retrieval solution, pH 6.0, for 30 s at 1201C),
factor XIIIA Ab-1 (1:500), and CD31 (1:20) (both pretreated with
citrate buffer, pH 6.0, for 60 s at 1201C: 10.5 g citric acid
monohydrate in 5 l H2O, pH 6.0), followed by biotinylated rabbit
anti-mouse IgG and streptavidin–biotin alkaline phosphatase. Sec-
tions were developed using Fast Red and nuclei were counterstained
Table 2. Characterization of patient tissues
Age Gender Location Operation due to
(a) Specimens of younger, sun-protected skin
361 F Breast2 Mammary reduction
28 F Breast2 Mammary reduction
34 F Breast2 Mammary reduction
38 F Breast2 Mammary reduction
25 F Breast2 Mammary reduction
19th
week of
gestation
F Abdomen Intrauterine death
(b) Specimens of older, sun-protected skin
75 F Breast2 Breast ablation due to cancer
79 F Breast2 Breast ablation due to cancer
761 F Breast2 Breast ablation due to cancer
78 F Breast2 Breast ablation due to cancer
59 F Breast2 Breast ablation due to cancer
75 F Breast2 Breast ablation due to cancer
(c) Specimens of older, sun-protected skin
92 F Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
63 M Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
86 F Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
67 M Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
69 M Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
701 F Popliteal
fossa
Arterial occlusive disease
(above-knee amputation)
(d) Specimens of older, sun-exposed skin
65 F Face, jowl Actinic keratosis with dysplasia
57 M Face, front Squamous cell carcinoma
91 M Face, jowl Squamous cell carcinoma
65 F Face, jowl Actinic keratosis with dysplasia
621 F Face, ear Seborrheic keratosis
62 M Face, alar
wing of the
nose
Basal cell carcinoma
65 F Face, jowl Actinic keratosis with dysplasia
87 M Face, front Squamous cell carcinoma
63 M Face, alar
wing of the
nose
Basal cell carcinoma
53 F Face, ear Seborrheic keratosis
1Displayed in Figure 1.
2Mainly from the lateral quadrant.
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with hematoxylin. RAGE was detected with the catalyzed signal
amplification system as described (van Gijlswijk et al., 1996) using
biotinylated tyramin, which was applied after the streptavidin–
biotin–peroxidase complex. The biotinylated tyramin was then
enzymatically cleaved, resulting in localized precipitation of biotin,
followed by detection with the streptavidin–biotin–alkaline phos-
phatase complex. In control experiments, non-immune mouse IgG1
and phosphate-buffered saline replaced primary and secondary
antibodies, respectively, with the same processing of the samples as
described above. All controls showed no stainings (data not shown).
In order to evaluate the expression levels of RAGE inside the
dermis, we used semiquantitative analysis with a scale from weak
(þ ), to moderate (þ þ ) and strong (þ þ þ ) intensity by
investigating 10 different areas per specimen.
Synthesis of CML-BSA
BSA (2.65 mM) and NaCNBH3 (0.45 M) were dissolved in 10 ml 0.2 M
phosphate buffer, pH 7.8, followed by addition of 0.255 M glyoxylic
acid and incubation at room temperature for 48 hours. The reaction
product was dialyzed against water and lyophilized. Control BSA
was handled the same way, but without the addition of glyoxylic
acid. Protein concentrations were adjusted by the Bio-Rad protein
assay and endotoxin was removed with endotoxin-removing gel and
the residual endotoxin measured with the limulus amebocyte lysate
test (endotoxin concentration in both preparations o0.02 ng/ml).
Glycation of CML-BSA was determined with the 2,4,6-trinitro-
benzenesulfonic acid assay (Fields, 1972), yielding a glycation rate
of 36.5%.
Cell culture
HFFs were kindly provided by Dr M. Marschall (Institute for Virology,
University of Erlangen-Nuernberg, Germany). Cells were maintained
in 75 cm2 cell culture flasks in a humidified atmosphere with 5% CO2
at 371C and DMEM supplemented with 10% heat-inactivated fetal
calf serum and 1% penicillin (100 IU/ml) and streptomycin (100 mg/
ml). Only cells that tested mycoplasma-negative and that were prior
to their 15th passage were used for experiments.
Treatment of cells and protein extraction
HFFs were seeded at 20,000 cells per well in 24-well plates and
when reaching a preconfluent stage were incubated in 500 ml
starvation medium (DMEM containing 1% penicillin/streptomycin
and 0.125% fetal calf serum) for 24 hours. Then, cells were treated
with 10–100 mg/ml CML-BSA, 50 mg/ml control BSA, or 0–10 ng/ml
TNF-a for 24 hours, followed by washing with ice-cold phosphate-
buffered saline and lysis in a buffer containing 0.06 M Tris,
pH 6.8, 2% SDS, 8% glycerol, 1 M urea, and 10 mg/ml dithiothreitol.
Lysates were heated at 951C for 5 min and stored at 201C until
further use.
SDS-PAGE and Western blotting
Lysates were subjected to SDS-PAGE and blotted onto nitrocellulose
membranes. Membranes were blocked in 3% BSA and incubated
overnight with monoclonal anti-RAGE (1:100) and anti-b-actin
(1:5,000) antibodies, followed by anti-mouse IgG conjugated to
peroxidase (1:5,000). Bands were visualized by enhanced chemi-
luminescence and quantified densitometrically using the BioDoc
Analyzer (Biometra, Goettingen, Germany).
Real-time PCR for ECM-related gene expression
RNA of treated cells was extracted using peqGOLD RNAPureTM
according to the manufacturer’s recommendations. Extracted RNA
was resuspended in 18 ml of RNase-free water and 2ml each was
used to measure the RNA concentration by UV spectroscopy at
260 nm and to determine RNA integrity on an agarose gel. The
solubilized RNA was frozen immediately and stored at 801C until
use. A 1 mg portion of RNA was reverse-transcribed into cDNA using
100 pmol oligo-dT, 50 pmol random primer, and 100 U Superscript II
following the recommendations of the supplier. The cDNA was
stored at 201C until use.
Table 3. Sequences of human primers and probes used
for real-time PCR
mRNA Oligonucleotide Sequence (50-30)
GAPDH GAPDH sense CCA CAT CGC TCA GAC ACC AT
GAPDH antisense CCA GGC CAA TAC G
GAPDH probe AAG GTG AAG GTC GGA GTC AAC
GGA TTT G
RAGE RAGE sense ACC AGG GAA CCT ACA GCT GTG T
RAGE antisense TAG AGT TCC CAG CCC TGA TCC T
RAGE probe CAT CAG CAT CAT CGA ACC AGG
CGA GGA
CTGF CTGF sense AAC CGC AAG ATC GGC GT
CTGF antisense CCG TAC CAC CGA AGA TGC A
CTGF probe TGC ACC GCC AAA GAT GGT GCT C
TGF-b TGF-b sense TGC GTC TGC TGA GGC TCA A
TGF-b antisense TTG CTG AGG TAT CGC CAG GA
TGF-b probe ACG TGG AGC TGT ACC AGA AAT
ACA GCA ACA
PC-a1(I) PC-a1(I) sense CAG AAG AAC TGG TAC ATC AGC
AAG A
PC-a1(I) antisense GTC AGC TGG ATG GCC ACA T
PC-a1(I) probe ACC GAT GGA TTC CAG TTC GAG
TAT GGC
MMP-1 MMP-1 sense CAG TGG TGA TGT TCA GCT AGC
TCA
MMP-1 antisense GCC GAT GGG CTG GAC A
MMP-1 probe CAT CCA AGC CAT ATA TGG ACG
TTC CCA AA
MMP-2 MMP-2 sense GAG GAC TAC GAC CGC GAC AA
MMP-2 antisense TTG TTG CCC AGG AAA GTG AAG
MMP-2 probe TCT GCC CTG AGA CCG CCA TGT CC
MMP-3 MMP-3 sense GTT CCG CCT GTC TCA AGA TGA
MMP-3 antisense TAC CCA CGG AAC CTG TCC C
MMP-3 probe TAA ATG GCA TTC AGT CCC TCT ATG
GAC CTC C
MMP-12 MMP-12 sense CGC CTC TCT GCT GAT GAC ATA C
MMP-12 antisense TCA GTC CCT GTA TGG AGA CCC
AAA AGA GAA
MMP-12 probe CAG GAT TTG GCA AGC GTT G
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Real-time RT-PCR was performed on a LightCycler (Roche,
Mannheim, Germany) using the TaqMan principle in a reaction
volume of 15 ml (Dotsch et al., 2001). The mix included FastStart Taq
DNA polymerase, dNTP mix, reaction buffer, 3 mM MgCl2, 2 mM
each of the primers, and 0.5 mM of the probe. After pipetting 13.5ml
of this mixture into LightCycler capillaries, 1.5 ml template cDNA
was added. The capillaries were sealed and placed into the thermal
chamber of the LightCycler. Samples were amplified with a
precycling step at 951C for 10 min, followed by 40 cycles of
denaturation at 951C for 0.1 s, annealing at 601C for 15 s, and
extension at 721C for 6 s. Data were analyzed according to a
standard curve generated from a dilution series of a mixture of
representative samples. For normalization of differences in RNA
amounts and efficiencies in the reverse transcription reactions, the
housekeeping gene GAPDH was co-amplified.
The specific sense and antisense oligonucleotide primers and
probes (Table 3) were designed based on published sequences.
Probes were labeled with a reporter dye (FAM, spanning exon
boundaries to avoid co-amplification of genomic DNA) at the 50 end
and a quencher dye (TAMRA) at the 30 end and were synthesized at
MWG Biotech AG (Ebersberg, Germany).
Statistics
All statistical analyses were performed using Microsofts EXCEL 2000.
The statistical significance of differences was determined using the
unpaired Student’s t-test. Differences with P-values o0.05 were
considered statistically significant. All graphs represent the mean7
standard deviation (SD) and were performed at least in triplicate.
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